1 |
Chu, 2015. Donor hepatic steatosis and outcome after liver transplantation: a systematic Review. |
Systematic review |
To evaluate the impact of liver steatosis on the results of transplantation. |
Graft: macrovesicular steatosis >30%. |
I |
2 |
Ghabril, 2016. Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients. |
Historical cohort |
To determine the impact of portal vein thrombosis (PVT) on the patient after hepatic transplantation and graft survival, waiting list results and factors associated with PVT. |
Recipient: pre-transplant portal vein thrombosis in. |
III |
3 |
Beck-Schimmer, 2015. Conditioning with sevoflurane in liver transplantation: results of a multicenter randomized controlled trial. |
Randomized clinical trial |
Examining whether volatile anesthetics have an effect on acute graft injury and clinical outcomes after liver transplantation. |
Recipient: anesthetic propofol. |
II |
4 |
Maggi, 2014. Ischemia time and liver transplantation, today. |
Historical cohort |
To evaluate the impact of the time of ischemia and other clinical factors in the development of PNF. |
Donor: age >60 years and female. Graft: time of ischemia >10h. Recipient: plasma consumption >30UI. Logistics: surgical time. |
III |
5 |
Lee, 2016. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. |
Historical cohort |
Use of EGD as an intermediate outcome measure and to identify donor, recipient and perioperative risk factors. |
Donor: cardiac death. |
III |
6 |
Fukazawa, 2013. Crystalloid fl ush with backward unclamping may decrease post-reperfusion cardiac arrest and improve short-term graft function when compared to portal blood flush with forward unclamping during liver transplantation. |
Historical cohort |
To compare two methods of reperfusion: crystalloid infusion with retrograde depletion and infusion of portal blood with post-anastomosis de-flushing. |
Graft: flush technique and retrograde reperfusion. |
III |
7 |
Angelico, 2014. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study. |
Historical cohort |
Generate a robust predictive model of early graft loss after hepatic transplantation. |
Donor: age >60 years, BMI and height. Graft: cold ischemia time (CIT). Recipient: creatinine, bilirubin, disease etiology, previous surgery of the upper abdomen and portal thrombosis. |
III |
8 |
Cortes, 2014. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction. |
Historical cohort |
To investigate if there is a preoperative metabolic biomarker of the donor associated to EGD. |
Graft: metabolic profile. |
III |
9 |
Silberhumer, 2013. The difficulty in defining extended donor criteria for liver grafts:the Eurotransplant experience. |
Historical cohort |
To analyze the impact of donor-specific risk factors, independent of the characteristics of the recipient. |
Donor: Sodium >160mmol/l, gamma glutamyl transferase (GGT), cardiac death and gender (female). Graft: CIT>12h. |
III |
10 |
Hoyer, 2015. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. |
Historical cohort |
To evaluate donor predictive information for the development of EGD. |
Donor BMI, GGT, macrosteatosis. Graft: CIT. |
III |
11 |
Dutkowski, 2012. The use of fatty liver grafts in modern allocation systems risk assessment by the balance of risk (BAR) score. |
Historical cohort |
To integrate the amount of hepatic steatosis in the modern liver allocation system. |
Graft: liver macrosteatosis > 30%. |
III |
12 |
Lee, 2014. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in lower survival. |
Historical cohort |
To investigate the incidence and ratios of EGD and its role in predicting morbidity and mortality in hepatic recipients from brain death donors. |
Donor: cardiac death. |
III |
13 |
Taner, 2012. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. |
Historical cohort |
To determine the factors that cause graft loss and the development of ischemic cholangitis and compare the survival of patients with grafts from CPR and brain death donors. |
Donor: cardiac death. Logistics: time elapsed between asystole and aortic clamping. Recipient: race: African-American. |
III |
14 |
Blok, 2012. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. |
Cohort |
To validate the Donor Risk Index (DRI) in Eurotransplant. |
Donor: DRI. Recipient: age, Model for End-Stage Liver Disease (MELD) and underlying disease (Viral Cirrhosis C). |
III |